Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

08. Décembre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2919


	Articles 1 - 20 / 58373

	Adaptive Drug Resistance Mechanisms Driven by Non-coding RNA-Protein Interaction Networks in Hepatocellular Carcinoma. Crit Rev Oncol Hematol Tian Y, Ouyang K, Wu H, Liao H, He L, Luo T, Ma K, Mao X, Wang F, Xiong H. PMID: 41354412 [PubMed - as supplied by publisher]
	Does Adjuvant Therapy in Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas Improve Survival? A Systematic Review and Meta-Analysis Using Trial Sequential Analysis. World J Surg Ingaldi C, D'Ambra V, Ricci C, Alberici L, Migliori M, Di Marco M, Palloni A, Mosconi C, Serra C, Casadei R. PMID: 41353715 [PubMed - as supplied by publisher]
	An ultrasensitive miRNA-25 aptasensor based on Co@CNTs nanoaggregates for early detection of pancreatic cancer. Biosens Bioelectron Han Y, Zhou M, Zhu M, Zhang W, Liu Y, Liu T, Chu Z, Jin W. PMID: 41352058 [PubMed - as supplied by publisher]
	Pathogenic CDKN2A germline variants are rare in a cohort of unselected pancreatic cancer patients from Pakistan. Fam Cancer Arif S, Muhammad N, Naeemi H, Rashid MU. PMID: 41351753 [PubMed - indexed for MEDLINE]
	Development of a nomogram for predicting microvascular invasion in patients with hepatocellular carcinoma. BMC Cancer Li J, Huo S, Ma J, Ren L, Liu L, Lu Y, Tang S, Chen D, Jin L, Liao W. PMID: 41350826 [PubMed - indexed for MEDLINE]
	Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and prognostication of pancreatic cancer. NPJ Precis Oncol Shishido SN, Suresh D, Mason J, Liu Q, Park K, Watson R, Nissen N, Gaddam S, Lo SK, Pandol S, Kuhn P. PMID: 41350390 [PubMed - as supplied by publisher]
	Poly (ADP-ribose) polymerase (PARP) inhibitors approved for the treatment of cancer. Pharmacol Res Roskoski R Jr. PMID: 41349848 [PubMed - as supplied by publisher]
	Mechanistic insights into the dynamics of plasma membrane repair in cancer. Mol Biol Rep Huang Y, Ullah A, Ali MM. PMID: 41348266 [PubMed - indexed for MEDLINE]
	Targeting emerging amino acid dependencies and transporters in cancer therapy. Front Pharmacol Akinlalu A, Ogberefor E, Gao T, Sun D. PMID: 41347155 [PubMed]
	Risk factors and early prediction of pancreatic cancer among patients with diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne) Cong H, Song J, Liu L, Liu S, Wu H, Nan Z. PMID: 41347135 [PubMed - indexed for MEDLINE]
	Extracellular derived-exosomal micrornas in pancreatic cancer: investigating their diagnostic importance and potential targets for the prevention and treatment in pancreatic cancer. Front Oncol Mir R, Jan U, Barnawi J, Algehainy NA, Jalal MM, Altayar MA, Almotairi RM, Alnour TM, Mustafa SK, Al-Otaibi AS, Althaqafy AD, Alhathli EM, Alrdahe S, Mir MM, Sageer NZ, Babakr AT, Khan AA. PMID: 41347080 [PubMed]
	Prognostic differential subpopulation classification and immunotherapy response prediction in pancreatic cancer patients based on the gene features of necrotizing apoptosis. Front Immunol Liao K, Fu Z, Liu X, Yu X, Jin L, Cheng J, Yang D, Ai K, Liu Z, Guo D, Liu S, Yan X, Li Z, Xu M, Yan X, Gan J, Cheng Z, Zhu W, Cai M, Xu W, Li Z, Xu J, Wang X. PMID: 41346619 [PubMed - indexed for MEDLINE]
	New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer. Br J Cancer Springfeld C, Hackert T, Palmer DH, Öhlund D, Peccerella T, Hank T, Büchler MW, Michalski CW, Neoptolemos JP. PMID: 41345265 [PubMed - as supplied by publisher]
	Clinical Practice Guidelines for Pancreatic Cancer 2025 From the Japan Pancreas Society: A Synopsis. Pancreas Abe T, Nakamura M, Morizane C, Yoshida M, Kitano M, Ohtsuka T, Nakata K, Someya M, Mizuno N, Nakai Y, Ozaka M, Hanada K, Masamune A, Committee for the Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society. PMID: 41342569 [PubMed - as supplied by publisher]
	Harnessing the power of cancer-associated fibroblasts to revolutionize pancreatic cancer treatment. Cancer Biol Med Shen J, Wu R, Yin T, Wang Q, Nie L. PMID: 41342564 [PubMed - as supplied by publisher]
	The mediating role of inflammation in cancer risk among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study. Int J Surg Bu J, Mi N, Liang Z, Xie P, Long C, Yang M, Yuan J, Xia B, Liu A, Xiang S, He Q. PMID: 41342547 [PubMed - as supplied by publisher]
	Sintilimab as adjuvant therapy for high-risk hepatocellular carcinoma after curative resection: a multicentric retrospective cohort study. Eur J Gastroenterol Hepatol Xu XL, Su JY, Zhang Y, Su Z, Liu SP, Chen SC, Ou JJ, Peng N, Chen CY, Shao JN, He X, Liu WX, Yang DL, Pan LX, Deng ZJ, Huo RR, Guo PP, Ma L, Ma YL, Zhong JH. PMID: 41342314 [PubMed - as supplied by publisher]
	Computed Tomography-Guided Versus Fluoroscopy-Guided Celiac Plexus Neurolysis for Pancreatic Cancer Pain: A Novel Comparative Study Integrating Pain Phenotyping and Functional Outcomes. Indian J Palliat Care Kumar S, Singh S, Singh V, Kumar M, Singh MK. PMID: 41342026 [PubMed]
	Reprogramming the tumor microenvironment to overcome immunotherapy resistance in pancreatic cancer. Front Immunol Hui X, Tian X, Ding S, Sun A, Zhao T, Wang H. PMID: 41341574 [PubMed - indexed for MEDLINE]
	Melatonin combined with antineoplastic drugs or natural products for cancer treatment: An update. Curr Res Pharmacol Drug Discov Trejo-Solís C, Rojas-Tomé IS, Jung-Cook H, Palomares-Alonso F. PMID: 41341468 [PubMed]

Articles 1 - 20 / 58373

Page 1 de 2919



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité